JPRN-UMIN000018106招募中未知
Treatment outcomes in wet age-related macular degeneration using a Treat-and-Extend regimen. - Treatment outcomes in wet AMD using Treat-and-Extend regimen.
Department of Ophthalmology, Kagawa university faculty of medicine0 个研究点目标入组 150 人开始时间: 2015年6月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Greatest Linear Dimension (GLD) of the total lesion area <12 Macular Photocoagulation Study Disc Areas 2) Presence of subretinal hemorrhage, scar or macular fibrosis (>50% lesion area) 3) Prior treatment with anti-VEGF drug, photodynamic therapy 4) Prior treatment with dexamethasone (<6 months) or triamcinolone (<30 days), intraocular surgery (<3 months) 5) Active intraocular inflammation 6) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 7) Patient who the doctor in charge judges are ineligible for the study
研究者
相似试验
尚未招募
不适用
Clinical study of wet age-related macular degeneration with Traditional Chinese medicine and Western medicineITMCTR2200006375Shanghai Eye Disease Prevention and Treatment Center
尚未招募
不适用
Fellow Eye Effect with Ranibizumab for Age Related Macular DegeneratioACTRN12607000575437Monash University25
进行中（未招募）
不适用
Treatment of neovascular age related macular degeneration with intravitreal Bevacizumab (Avastin)neovascular age-related macular degenerationEUCTR2006-001914-34-DEBert Mueller, Dep. Ophthalmology
终止
2 期
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With RanibizumabAge-Related Macular DegenerationNCT01402544University of California, San Diego20
已完成
不适用
Treating neovascular age-related macular degeneration with aflibercepteovascular age-related macular degenerationEye DiseasesISRCTN58955026York Hospital40